湖北济川药业股份有限公司关于 以集中竞价交易方式首次回购股份的公告

Group 1 - The company has approved a share repurchase plan using its own funds, with a total amount not less than RMB 25 million and not exceeding RMB 50 million, at a price not exceeding RMB 38 per share [2] - The repurchase period is set to be within 12 months from the board's approval date [2] Group 2 - As of January 13, 2026, the company has repurchased 100,000 shares, accounting for 0.01% of the total share capital, with a total payment of RMB 2,619,944 [3] - The repurchase price ranged from RMB 26.13 to RMB 26.28 per share, in compliance with the approved repurchase plan [3] - The company will continue to make repurchase decisions based on market conditions and will fulfill its information disclosure obligations [3]